SUMMARY This study was undertaken to estimate the incidence of cerebrovascular disease in the age group 0-35 years in the population of Iceland during the 11 year period 1958 through 1968. The incidence for the whole country was 7.9/100,000 -males 7.5 and females 8.4. The incidence in Reykjavik, 8.3/100,000, was not significantly different from the rest of the country (7.2/100,000) nor was there any significant difference between the sexes. Comparison is made with similar studies.
Material and Methods
The collection of data started in 1967. The study period was from January 1, 1958, through December 31, 1968 and included all individuals in the age group 0-35 years in whom the following diagnosis of cerebrovascular diseases had been made: 1) subarachnoidal hemorrhage (SAH); 2) cerebral aneurysm; 3) cerebral arteriovenous malformation (AVM); 4) cerebral angioma; 5) cerebral thrombosis (CT); 6) cerebral embolism (CE); 7) cerebral hemorrhage (CH); 8) transient ischemic attacks (TIA).
The records of such patients in the capital and rural hospitals, were critically reviewed. Further information regarding individual patients was obtained by many visits to district medical officers and rural hospitals and by interviewing relatives of the patients.
No additional cases to those already on file in hospitals or in the department of pathology and on death certificates were discovered by personal contact with the county physicians. This makes it improbable that patients in this young age group, with symptoms suggesting one of the diagnoses listed above, would be overlooked. We feel it should be stressed that county physicians are in close personal contact with the population they serve.
The authors examined 56 of the patients. The total number of autopsies conducted at the Department of Pathology (University of Iceland) during the period of study was 5,604 (1,076 coroners). All these post-mortem reports and all death certificates issued during the 11 year study period which contained one of the suggestive diagnoses, were reviewed by the authors. The diagnostic criteria for inclusion of cases in the series were those of Matsumoto et al.* Table 1 shows the source of information and the place of residence at the onset of illness.
Result
A total of 105 patients, 59 males and 46 females, fulfilled the diagnostic criteria, and were included in the study. Eight of these were 35-years-old, but 97 were younger, (see table  3 ). Of 105 patients 73 (or 77%) were admitted to hospital, (table 1) .
Examination of death certificates identified 20 patients. Adequate additional information was available in 13 of the cases from autopsy (9), hospital records (3) and practitioner (1) . Seven patients were included on information contained in the death certificates alone.
Of the 105 patients SAH accounted for 44 and CH for 41, that is, 85 (81%) suffered an intracranial hemorrhage. Only 4 suffered from occlusive vascular disease and in 16 the etiology was unknown.
During the eleven year period 65 patients (61.9%) died, 37 males and 28 females. Autopsy was performed on 46 (70.8%) revealing 14 SAH, 31 CH and 1 CT.
The mortality of those who lived in Reykjavik was 31 (60.8%), males 68.9%, females 50.0%. In rural areas, the mortality was 35 (62.9%), males 56.7% and females 70.8%.
Mortality of patients with SAH was 45.5%, in hereditary cerebral hemorrhage 4 it was 77.8%, and in the remaining patients with cerebral hemorrhage, excluding the hereditary variety, was 73.9%. Table 2 shows the age and sex distribution of the population at risk in Iceland, on December 1, 1963, mid-study period.
2 Table 3 gives the number of cases and age specific average annual incidence rate per 100,000 population in Iceland 1963.
The incidence for the entire country was 7.92 per 100,000 per year, males 7.51, females 8.35.
The incidence was slightly higher for Reykjavik, 8.33 (males 9.40, females 7.24), than for the rest of the country 7.21 (males 7.73, females 6.64). This difference is not significant. ) and Finland with 0.14 million life years (13 patients). The incidence in Iceland for 0-34 years is 7.5 per 100,000. This is similar to the Finnish study, 7.7 per 100,000, but higher than Rochester, 4 per 100,000 (p < 0.05) and Jerusalem, 2.5 per 100,000.
In the Icelandic study there is no significant difference in incidence between sexes or urban and rural population. Mortality is the same in urban and rural areas.
Specific differences in the present survey are the large number of patients in the 0-19 age group 37 (35.2%), the hereditary cerebral hemorrhages 18 (17.1%) (as far as we know unique to Iceland) and the low incidence of thromboembolic disease 4 (3.8%), (table 6) .
We have no explanation for the low incidence of thromboembolic disease, but find it unlikely to be due to diagnostic inaccuracy.
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ALTHOUGH THE POTENTIAL of electroencephalography in assessing the functional state of the cerebrum is well known, EEG monitoring during anesthesia has not gained wide acceptance. The complexity and nonspecific nature of EEG information, the difficulty in assessing trends From the Departments of Anesthesiology and Neurosciences, University of California, San Diego, School of Medicine, La Jolla, California.
in EEG activity as it is displayed conventionally, and the high cost and space requirement of recording equipment are the chief reasons for the lack of acceptance. The difficulty in interpreting and quantifying changes in activity probably represents the most serious shortcoming of conventional EEG monitoring for anesthesiologists. A major consideration is that the anesthesiologist has limited time to study the primary EEG record as it is being recorded. Even when there is time to peruse the conventional voltage vs. time tracing,
